Commission Directive 2005/34/EC of 17 May 2005 amending Council Directive 91/414/EEC to include etoxazole and tepraloxydim as active substances.
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement, but no longer in force in the Agreement Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
143/2005 In force in the EEA
No Legal documents
Commission Directive 2005/34/EC of 17 May 2005 amending Council Directive 91/414/EEC to include etoxazole and tepraloxydim as active substances.
Tilskipun framkvæmdastjórnarinnar 2005/34/EB frá 17. maí 2005 um breytingu á tilskipun ráðsins 91/414/EBE í því skyni að bæta við virku efnunum etoxasóli og tepraloxýdími
Richtlinie 2005/34/EG der Kommission vom 17. Mai 2005 zur Änderung der Richtlinie 91/414/EWG des Rates zwecks Aufnahme der Wirkstoffe Etoxazol und Tepraloxydim
Kommisjonsdirektiv 2005/34/EF av 17. mai 2005 om endring av rådsdirektiv 91/414/EØF med henblikk på oppføring av etoksazol og tepraloksydim som aktive stoffer
History
03.12.2005
Adopted JCD confirmed entry into force date
03.12.2005
Compliance date in the EEA
02.12.2005
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
27.09.2005
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
17.05.2005
Adoption date in the EU
01.12.2005
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.